Применение макролидов в амбулаторной терапии инфекций нижних дыхательных путей
Применение макролидов в амбулаторной терапии инфекций нижних дыхательных путей
Цой А.Н., Лазарева Н.Б., Бердникова Н.Г. Применение макролидов в амбулаторной терапии инфекций нижних дыхательных путей. Consilium Medicum. 2008; 10 (10): 5–9.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Список литературы
1. Wilson R. Bacteria, antibiotics and COPD. Eur Respir J 2001; 17: 995–1007.
2. Woodhead M, Blasi F, Ewig S et al. Guidelines for the management of adult lower respiratory tract infections.Eur Respir J 2005; 26: 1138–80.
3. Guidelines for the Management of Adults with Community-acquired Pneumonia. Diagnosis, Assessment of Severity, Antimicrobial Therapy, and Prevention. Am J Respir Crit Care Med 2001; 163: 1730–54.
4. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Torax 2001; 56 (Suppl. 4).
5. Pauwels RA, Buist AS, Calverley PMA et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1256–76.
6. Bandi V, Jakubowycz M, Kinyon C et al. Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae. FEMS Immunol Med Microbiol 2003; 37: 69–75.
7. Bartlett JG et al. Practice guidelines for management of community-acquired pneumonia in adults. Guidelines from the infectious diseases of America. Clin Infect Dis 2000; 31: 347–82.
8. Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN. The Alexander Project 1998–2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003; 52: 229–46.
9. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Disclosure forms for GOLD Committees are posted on the GOLD Website, 2006. www.goldcopd.org
10. Cazzola M, Blasi F, Allegra L. Critical evaluation of guidelines for the treatment of lower respiratory tract bacterial infections. Respiratory Medicine, 2001; 95 (2).
11. Mandell, Wunderink, Anzueto et al. IDSA/ATS Guidelines for CAP in Adults. CID 2007; 44 (Suppl. 2).
12. Практическое руководство по антиинфекционной химиотерапии. Под ред. Л.С.Страчунского, Ю.Б.Белоусова, С.Н.Козлова. 2007. Сайт: http://www.antibiotic.ru
13. Antibiotics and the Lung. Ed. by M.Cazzola, F.Blasi, S.Ewig. European Respiratory Momograph. 2004; 9: 28.
14. Tamaoki J. The effects of macrolides on inflammatory cells. Chest 2004; 125 (Suppl.): 41S–51S.
15. Peters DH, Friedel HA, McTavish D. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drug 1992; 44: 750–99.
16. Dorca J, Pardones S, Manresa F. Macrolides and lower respiratory tract infections. European Respiratory Momograph. 2004; 9 (28): 78–94.
17. Архипов В.В. Антибактериальная терапия инфекций нижних дыхательных путей в амбулаторной практике с позиций доказательной медицины. Атмосфера. Аллергол. и пульмонол. 2003; 1: 40–2.
2. Woodhead M, Blasi F, Ewig S et al. Guidelines for the management of adult lower respiratory tract infections.Eur Respir J 2005; 26: 1138–80.
3. Guidelines for the Management of Adults with Community-acquired Pneumonia. Diagnosis, Assessment of Severity, Antimicrobial Therapy, and Prevention. Am J Respir Crit Care Med 2001; 163: 1730–54.
4. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Torax 2001; 56 (Suppl. 4).
5. Pauwels RA, Buist AS, Calverley PMA et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1256–76.
6. Bandi V, Jakubowycz M, Kinyon C et al. Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae. FEMS Immunol Med Microbiol 2003; 37: 69–75.
7. Bartlett JG et al. Practice guidelines for management of community-acquired pneumonia in adults. Guidelines from the infectious diseases of America. Clin Infect Dis 2000; 31: 347–82.
8. Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN. The Alexander Project 1998–2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003; 52: 229–46.
9. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Disclosure forms for GOLD Committees are posted on the GOLD Website, 2006. www.goldcopd.org
10. Cazzola M, Blasi F, Allegra L. Critical evaluation of guidelines for the treatment of lower respiratory tract bacterial infections. Respiratory Medicine, 2001; 95 (2).
11. Mandell, Wunderink, Anzueto et al. IDSA/ATS Guidelines for CAP in Adults. CID 2007; 44 (Suppl. 2).
12. Практическое руководство по антиинфекционной химиотерапии. Под ред. Л.С.Страчунского, Ю.Б.Белоусова, С.Н.Козлова. 2007. Сайт: http://www.antibiotic.ru
13. Antibiotics and the Lung. Ed. by M.Cazzola, F.Blasi, S.Ewig. European Respiratory Momograph. 2004; 9: 28.
14. Tamaoki J. The effects of macrolides on inflammatory cells. Chest 2004; 125 (Suppl.): 41S–51S.
15. Peters DH, Friedel HA, McTavish D. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drug 1992; 44: 750–99.
16. Dorca J, Pardones S, Manresa F. Macrolides and lower respiratory tract infections. European Respiratory Momograph. 2004; 9 (28): 78–94.
17. Архипов В.В. Антибактериальная терапия инфекций нижних дыхательных путей в амбулаторной практике с позиций доказательной медицины. Атмосфера. Аллергол. и пульмонол. 2003; 1: 40–2.
Авторы
А.Н.Цой, Н.Б.Лазарева, Н.Г.Бердникова
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.